NULIBRY

View On IPO.GOV.UK

Registered

on 17 Dec 2020

Last Applicant/ Owned by

Sentynl Therapeutics, Inc.

Suite 200, 420 Stevens Avenue, Solana Beach

, California, 92075

Serial Number

UK00003569131 filed on 17^th Dec 2020

Registration Number

UK00003569131 registered on
23^rd Apr 2021

Correspondent Information

Beck Greener LLP

Fulwood House, 12 Fulwood Place

London,

WC1V 6HR

NULIBRY

pharmaceutical preparations for the treatment of rare diseases. pharmaceutical research and development.

Classification Information

Pharmaceutical preparations for the treatment of rare diseases.

Pharmaceutical research and development.

UK00003569131

Word

Individual